Restoration of mitochondria axonal transport by adaptor Disc1 supplementation prevents neurodegeneration and rescues visual function

Cell Rep. 2022 Sep 13;40(11):111324. doi: 10.1016/j.celrep.2022.111324.

Abstract

Deficits in mitochondrial transport are a common feature of neurodegenerative diseases. We investigated whether loss of components of the mitochondrial transport machinery impinge directly on metabolic stress, neuronal death, and circuit dysfunction. Using multiphoton microscope live imaging, we showed that ocular hypertension, a major risk factor in glaucoma, disrupts mitochondria anterograde axonal transport leading to energy decline in vulnerable neurons. Gene- and protein-expression analysis revealed loss of the adaptor disrupted in schizophrenia 1 (Disc1) in retinal neurons subjected to high intraocular pressure. Disc1 gene delivery was sufficient to rescue anterograde transport and replenish axonal mitochondria. A genetically encoded ATP sensor combined with longitudinal live imaging showed that Disc1 supplementation increased ATP production in stressed neurons. Disc1 gene therapy promotes neuronal survival, reverses abnormal single-cell calcium dynamics, and restores visual responses. Our study demonstrates that enhancing anterograde mitochondrial transport is an effective strategy to alleviate metabolic stress and neurodegeneration.

Keywords: CP: Neuroscience; disrupted in schizophrenia 1; glaucoma; metabolic stress; mitochondria axonal transport; neuronal ATP production; neuroprotection; retinal ganglion cell; vision restoration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Axonal Transport* / physiology
  • Dietary Supplements
  • Mitochondria / metabolism
  • Nerve Tissue Proteins* / metabolism

Substances

  • Nerve Tissue Proteins
  • Adenosine Triphosphate

Grants and funding